Table 2.
Genotype frequency of cases | Genotype frequency of controls | Genotype frequency | Minor allele | Minor allele frequencies | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SNP ID (allele1/allele2) | Position | 1/1 | 1/2 | 2/2 | 1/1 | 1/2 | 2/2 | χ 2 | p | Case | Control | χ 2 | p | OR | 95% CI | |
rs1695 (A/G) | 67585218 | 394 | 214 | 23 | 452 | 235 | 33 | 0.885 | 0.642 | G | 0.206 | 0.209 | 0.037 | 0.848 | 1.018 | 0.845-1.227 |
rs4680 (A/G) | 19963748 | 48 | 227 | 356 | 52 | 273 | 395 | 0.120 | 0.758 | A | 0.256 | 0.262 | 0.120 | 0.729 | 0.970 | 0.816-1.153 |
rs1800566 (C/T) | 69711242 | 177 | 330 | 124 | 219 | 337 | 164 | 4.239 | 0.120 | C | 0.458 | 0.462 | 0.039 | 0.843 | 1.015 | 0.873-1.182 |
rs4807542 (A/G) | 1104079 | 9 | 118 | 504 | 7 | 149 | 564 | 1.363 | 0.506 | A | 0.108 | 0.113 | 0.201 | 0.654 | 0.946 | 0.743-1.204 |
rs713041 (C/T) | 1106616 | 216 | 296 | 119 | 204 | 359 | 157 | 5.796 | 0.055 | T | 0.423 | 0.467 | 5.322 | 0.021 | 1.196 | 1.027-1.393 |
rs7579 (A/G) | 42800706 | 51 | 249 | 331 | 48 | 302 | 370 | 1.502 | 0.472 | A | 0.278 | 0.276 | 0.010 | 0.920 | 1.009 | 0.852-1.194 |
rs230813 (C/G) | 42798931 | 105 | 276 | 250 | 104 | 353 | 263 | 3.914 | 0.141 | C | 0.385 | 0.390 | 0.057 | 0.811 | 0.981 | 0.840-1.146 |
rs1004467 (C/T) | 102834750 | 80 | 279 | 272 | 97 | 326 | 297 | 0.522 | 0.770 | C | 0.348 | 0.361 | 0.516 | 0.473 | 0.944 | 0.806-1.105 |
rs3824755 (C/G) | 102836092 | 72 | 278 | 281 | 85 | 334 | 301 | 1.029 | 0.598 | C | 0.334 | 0.35 | 0.728 | 0.394 | 0.933 | 0.796-1.094 |
rs9932581 (C/T) | 88651945 | 107 | 337 | 187 | 159 | 355 | 206 | 5.714 | 0.057 | C | 0.437 | 0.467 | 2.567 | 0.109 | 0.883 | 0.759-1.028 |
Table 2 shows the results of oxidative stress-related genotype distribution and allele frequencies in PE and control groups. After correction for multiple comparisons (P/10), there was no significant difference at the oxidative stress-related SNPs among 10 groups, although the SNP rs713041 with a C/T polymorphism, the T allele looks like a risk allele for predisposition to PE (minor allele χ2 = 5.322, p = 0.021, p < 0.05; OR = 1.196, 95%CI = 1.027‐1.393). Similarly, for all other SNPs in Table 2, there were no significant differences in the remaining SNP loci between PE and control groups (rs1695: for genotype, p = 0.642, for allele, χ2 = 0.037, p = 0.848, OR = 1.018, 95%CI = 0.845‐1.227; rs4680: for genotype, p = 0.758, for allele, χ2 = 0.120, p = 0.729, OR = 0.970, 95%CI = 0.816‐1.153; rs1800566: for genotype, p = 0.120, for allele, χ2 = 0.039, p = 0.843, OR = 1.015, 95%CI = 0.873‐1.182; rs4807542: for genotype, p = 0.506, for allele, χ2 = 0.201, p = 0.654, OR = 0.946, 95%CI = 0.743‐1.204; rs713041: for genotype, p = 0.055; rs7579: for genotype, p = 0.472, for allele, χ2 = 0.010, p = 0.920, OR = 1.009, 95%CI = 0.852‐1.194; rs230813: for genotype, p = 0.141, for allele, χ2 = 0.057, p = 0.811, OR = 0.981, 95%CI = 0.840‐1.146; rs1004467: for genotype, p = 0.770, for allele, χ2 = 0.516, p = 0.473, OR = 0.944, 95%CI = 0.806‐1.105; rs3824755: for genotype, p = 0.598, for allele, χ2 = 0.728, p = 0.394, OR = 0.933, 95%CI = 0.796‐1.094; rs9932581: for genotype, p = 0.057, for allele, χ2 = 2.567, p = 0.109, OR = 0.883, 95%CI = 0.759‐1.028).